BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 15 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,603,000 | +68.6% | 322,413 | -1.8% | 6.64% | +87.0% |
| Q2 2020 | $7,473,000 | +171.6% | 328,475 | -8.1% | 3.55% | +28.0% |
| Q1 2020 | $2,751,000 | -72.5% | 357,240 | -66.8% | 2.77% | +4371.0% |
| Q4 2019 | $10,005,000 | +368.0% | 1,077,000 | +200.0% | 0.06% | -54.1% |
| Q3 2019 | $2,138,000 | +3.4% | 359,000 | 0.0% | 0.14% | -20.1% |
| Q2 2019 | $2,068,000 | +6.1% | 359,000 | 0.0% | 0.17% | -2.9% |
| Q1 2019 | $1,949,000 | +13.8% | 359,000 | 0.0% | 0.17% | -37.6% |
| Q4 2018 | $1,712,000 | -14.8% | 359,000 | 0.0% | 0.28% | -75.0% |
| Q3 2018 | $2,010,000 | -16.1% | 359,000 | 0.0% | 1.12% | -17.8% |
| Q2 2018 | $2,395,000 | +22.8% | 359,000 | 0.0% | 1.36% | -15.4% |
| Q1 2018 | $1,950,000 | +1.4% | 359,000 | 0.0% | 1.61% | +43.8% |
| Q4 2017 | $1,924,000 | – | 359,000 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 322,413 | $12,603,000 | 6.64% |
| MORGAN JESS S & CO INC | 74,464 | $2,911,000 | 2.90% |
| Mutual Advisors, LLC | 7,151 | $280,000 | 0.02% |
| BANK HAPOALIM BM | 6,510 | $254,000 | 0.01% |
| NEXT Financial Group, Inc | 1,350 | $53,000 | 0.01% |
| ARK Investment Management | 19,856 | $776,000 | 0.01% |
| HighTower Advisors, LLC | 17,900 | $701,000 | 0.00% |
| Edge Wealth Management LLC | 250 | $10,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 1,190 | $47,000 | 0.00% |
| ROYAL BANK OF CANADA | 3,607 | $141,000 | 0.00% |